These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 29968951

  • 1. MicroRNA-760 Inhibits Doxorubicin Resistance in Hepatocellular Carcinoma through Regulating Notch1/Hes1-PTEN/Akt Signaling Pathway.
    Tian T, Fu X, Lu J, Ruan Z, Nan K, Yao Y, Yang Y.
    J Biochem Mol Toxicol; 2018 Aug; 32(8):e22167. PubMed ID: 29968951
    [Abstract] [Full Text] [Related]

  • 2. microRNA-19a-3p promotes tumor metastasis and chemoresistance through the PTEN/Akt pathway in hepatocellular carcinoma.
    Jiang XM, Yu XN, Liu TT, Zhu HR, Shi X, Bilegsaikhan E, Guo HY, Song GQ, Weng SQ, Huang XX, Dong L, Janssen HLA, Shen XZ, Zhu JM.
    Biomed Pharmacother; 2018 Sep; 105():1147-1154. PubMed ID: 30021351
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA-383 inhibits doxorubicin resistance in hepatocellular carcinoma by targeting eukaryotic translation initiation factor 5A2.
    Tu C, Chen W, Wang S, Tan W, Guo J, Shao C, Wang W.
    J Cell Mol Med; 2019 Nov; 23(11):7190-7199. PubMed ID: 30801960
    [Abstract] [Full Text] [Related]

  • 4. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.
    He C, Dong X, Zhai B, Jiang X, Dong D, Li B, Jiang H, Xu S, Sun X.
    Oncotarget; 2015 Oct 06; 6(30):28867-81. PubMed ID: 26311740
    [Abstract] [Full Text] [Related]

  • 5. Long Noncoding RNA lncARSR Promotes Doxorubicin Resistance in Hepatocellular Carcinoma via Modulating PTEN-PI3K/Akt Pathway.
    Li Y, Ye Y, Feng B, Qi Y.
    J Cell Biochem; 2017 Dec 06; 118(12):4498-4507. PubMed ID: 28464252
    [Abstract] [Full Text] [Related]

  • 6. MicroRNA-132 and microRNA-212 mediate doxorubicin resistance by down-regulating the PTEN-AKT/NF-κB signaling pathway in breast cancer.
    Xie M, Fu Z, Cao J, Liu Y, Wu J, Li Q, Chen Y.
    Biomed Pharmacother; 2018 Jun 06; 102():286-294. PubMed ID: 29567542
    [Abstract] [Full Text] [Related]

  • 7. Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway.
    Fu X, Liu M, Qu S, Ma J, Zhang Y, Shi T, Wen H, Yang Y, Wang S, Wang J, Nan K, Yao Y, Tian T.
    J Exp Clin Cancer Res; 2018 Mar 12; 37(1):52. PubMed ID: 29530052
    [Abstract] [Full Text] [Related]

  • 8. miR-505 enhances doxorubicin-induced cytotoxicity in hepatocellular carcinoma through repressing the Akt pathway by directly targeting HMGB1.
    Lu L, Zhang D, Xu Y, Bai G, Lv Y, Liang J.
    Biomed Pharmacother; 2018 Aug 12; 104():613-621. PubMed ID: 29803174
    [Abstract] [Full Text] [Related]

  • 9. Suppression of microRNA-495 alleviates high-glucose-induced retinal ganglion cell apoptosis by regulating Notch/PTEN/Akt signaling.
    Zhang X, Yang Y, Feng Z.
    Biomed Pharmacother; 2018 Oct 12; 106():923-929. PubMed ID: 30119264
    [Abstract] [Full Text] [Related]

  • 10. miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27kip1 pathway.
    Wang DD, Yang SJ, Chen X, Shen HY, Luo LJ, Zhang XH, Zhong SL, Zhao JH, Tang JH.
    Tumour Biol; 2016 Nov 12; 37(11):15315-15324. PubMed ID: 27699665
    [Abstract] [Full Text] [Related]

  • 11. miR-218 modulate hepatocellular carcinoma cell proliferation through PTEN/AKT/PI3K pathway and HoxA10.
    Xiao ZD, Jiao CY, Huang HT, He LJ, Zhao JJ, Lu ZY, Liu LX.
    Int J Clin Exp Pathol; 2014 Nov 12; 7(7):4039-44. PubMed ID: 25120782
    [Abstract] [Full Text] [Related]

  • 12. Low‑intensity ultrasound enhances the antitumor effects of doxorubicin on hepatocellular carcinoma cells through the ROS‑miR‑21‑PTEN axis.
    Xia C, Zeng H, Zheng Y.
    Mol Med Rep; 2020 Mar 12; 21(3):989-998. PubMed ID: 32016465
    [Abstract] [Full Text] [Related]

  • 13. MiR-222 promotes drug-resistance of breast cancer cells to adriamycin via modulation of PTEN/Akt/FOXO1 pathway.
    Shen H, Wang D, Li L, Yang S, Chen X, Zhou S, Zhong S, Zhao J, Tang J.
    Gene; 2017 Jan 05; 596():110-118. PubMed ID: 27746366
    [Abstract] [Full Text] [Related]

  • 14. Knockdown of miR-25 increases the sensitivity of liver cancer stem cells to TRAIL-induced apoptosis via PTEN/PI3K/Akt/Bad signaling pathway.
    Feng X, Jiang J, Shi S, Xie H, Zhou L, Zheng S.
    Int J Oncol; 2016 Dec 05; 49(6):2600-2610. PubMed ID: 27840896
    [Abstract] [Full Text] [Related]

  • 15. Oroxin B Induces Apoptosis by Down-Regulating MicroRNA-221 Resulting in the Inactivation of the PTEN/PI3K/AKT Pathway in Liver Cancer.
    Li N, Men W, Zheng Y, Wang H, Meng X.
    Molecules; 2019 Nov 30; 24(23):. PubMed ID: 31801250
    [Abstract] [Full Text] [Related]

  • 16. MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.
    Xia H, Ooi LL, Hui KM.
    Hepatology; 2013 Aug 30; 58(2):629-41. PubMed ID: 23471579
    [Abstract] [Full Text] [Related]

  • 17. MiR-20a Induces Cell Radioresistance by Activating the PTEN/PI3K/Akt Signaling Pathway in Hepatocellular Carcinoma.
    Zhang Y, Zheng L, Ding Y, Li Q, Wang R, Liu T, Sun Q, Yang H, Peng S, Wang W, Chen L.
    Int J Radiat Oncol Biol Phys; 2015 Aug 01; 92(5):1132-1140. PubMed ID: 26031366
    [Abstract] [Full Text] [Related]

  • 18. miR-185 inhibits hepatocellular carcinoma growth by targeting the DNMT1/PTEN/Akt pathway.
    Qadir XV, Han C, Lu D, Zhang J, Wu T.
    Am J Pathol; 2014 Aug 01; 184(8):2355-64. PubMed ID: 24911372
    [Abstract] [Full Text] [Related]

  • 19. miR-1236 down-regulates alpha-fetoprotein, thus causing PTEN accumulation, which inhibits the PI3K/Akt pathway and malignant phenotype in hepatoma cells.
    Gao R, Cai C, Gan J, Yang X, Shuang Z, Liu M, Li S, Tang H.
    Oncotarget; 2015 Mar 20; 6(8):6014-28. PubMed ID: 25714026
    [Abstract] [Full Text] [Related]

  • 20. MiR-128-3p overexpression sensitizes hepatocellular carcinoma cells to sorafenib induced apoptosis through regulating DJ-1.
    Guo XL, Wang HB, Yong JK, Zhong J, Li QH.
    Eur Rev Med Pharmacol Sci; 2018 Oct 20; 22(20):6667-6677. PubMed ID: 30402839
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.